ILCC 2022 Conference Coverage

 

ILCC 2022 Conference Coverage
T

Neoadjuvant vs. Adjuvant Immunotherapy From the Surgeon's Perspective

By ILCC 2022 Conference Coverage FEATURING Tetsuya Mitsudomi
By ILCC 2022 Conference Coverage FEATURING Tetsuya Mitsudomi
1,103 views
August 29, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Videos
18:14

Systemic Therapy for Brain Metastases in NSCLC

ILCC 2022 Conference Coverage

E. Massarelli

943 views
17:29

Neoadjuvant vs. Adjuvant Immunotherapy From the Surgeon's Perspective

ILCC 2022 Conference Coverage

T. Mitsudomi

1.1K views
09:57

ILCC 2022 Mesothelioma: Updates in Systemic Therapy

ILCC 2022 Conference Coverage

P. Baas

250 views
01:21

Lecture Summary - 1L Single Agent Immunotherapy for mNSCLC

ILCC 2022 Conference Coverage

A. Chiang

14 views
14:33

1L Single Agent Immunotherapy for mNSCLC

ILCC 2022 Conference Coverage

A. Chiang

633 views
09:30

ILCC 2022 on The Role of PARP Inhibitors in DNA Damage Response in L…

ILCC 2022 Conference Coverage

P. Bunn

212 views